skip to Global Navigation Bar skip to main content


homeHome > About Us > Recruitment > News

News

News Content
Daewoong Pharmaceuticals expands entry to new markets with license in Mexico and India on Nabota
Date 2016-09-22 Hit 22386
list
News List
Prev Daewoong Pharmaceuticals disseminates the excellence of ‘Nabota’ in IMCAS
Next A global symposium pays attention to Nav 1.7 Chronic Pain Treatment, DWP17061.